Aldeyra Therapeutics
ALDX
119 hedge funds and large institutions have $186M invested in Aldeyra Therapeutics in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 23 reducing their positions, and 16 closing their positions.
74% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 23
56% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 16
40% more call options, than puts
Call options by funds: $5.07M | Put options by funds: $3.63M
6% more funds holding
Funds holding: 112 → 119 (+7)
1.09% more ownership
Funds ownership: 61.37% → 62.46% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $197M → $186M (-$11.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$3.34M |
| 2 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$2.03M |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$1.77M |
| 4 |
6CM
683 Capital Management
New York
|
+$1.49M |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$897K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$3.22M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.57M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.12M |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
-$1.46M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.3M |
ALDX Hedge Fund Activity: Q4 2024 in Review
119 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q4 2024, worth a combined $186M — down 5.6% from $197M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ALDX positions and 16 closed out — a net gain of 9 holders — while 40 added to existing stakes and 23 trimmed.
The largest buyer was Ardsley Advisory Partners, adding an estimated $3.34M. The largest seller was Invesco, cutting an estimated $3.22M.
- 119 institutional investors held Aldeyra Therapeutics (ALDX) as of Q4 2024, up from 112 in Q3 2024.
- Funds reported $186M of Aldeyra Therapeutics stock for Q4 2024, down 5.6% quarter-over-quarter.
- 25 funds opened new Aldeyra Therapeutics positions in Q4 2024 and 16 closed out, a net change of +9 holders.
- The largest Aldeyra Therapeutics buyer in Q4 2024 was Ardsley Advisory Partners, an estimated $3.34M added.
- The largest Aldeyra Therapeutics seller in Q4 2024 was Invesco, an estimated $3.22M sold.
Based on aggregated 13F filings for Q4 2024.